S
Sven Mahner
Researcher at Ludwig Maximilian University of Munich
Publications - 545
Citations - 12728
Sven Mahner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Ovarian cancer & Medicine. The author has an hindex of 46, co-authored 439 publications receiving 9126 citations. Previous affiliations of Sven Mahner include Charité & University of Hamburg.
Papers
More filters
Journal ArticleDOI
Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients
Heiko Schulz,Elisa Schmoeckel,Christina Kuhn,Simone Hofmann,Doris Mayr,Sven Mahner,Udo Jeschke +6 more
TL;DR: It was able to show that both tumor and stroma staining of Gal-1 could serve as negative prognostic factors for ovarian cancer, and cytoplasmic Gal-7 as anegative prognostic factor.
Journal ArticleDOI
Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective
Christina Fotopoulou,Jalid Sehouli,Giovanni Aletti,Philipp Harter,Sven Mahner,Denis Querleu,Luis Chiva,Hani Gabra,Nicoletta Colombo,Andreas du Bois +9 more
TL;DR: This research highlights the need to understand more fully the role of “cell reprograming” in the development of immune-oncology-related cancers.
Journal ArticleDOI
Systemic treatment of vulvar cancer
Sven Mahner,Katharina Prieske,Donata Grimm,Fabian Trillsch,Stefan Prieske,Gunhild von Amsberg,Cordula Petersen,Volkmar Mueller,Fritz Jaenicke,Linn Woelber +9 more
TL;DR: A review of the different systemic treatment options for patients with locally advanced, recurrent or metastatic vulvar cancer highlights the need for an international multicenter approach to identify the most effective therapeutic options.
Journal ArticleDOI
Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review)
TL;DR: Drawbacks and advantages of the technique are elucidated, whereas, the greatest advantage might be, that by selection of appropriate marker genes, also tumour cells, which have already undergone epithelial to mesenchymal transition can be detected.
Journal ArticleDOI
The prognostic significance of Jun transcription factors in ovarian cancer
Kerstin Eckhoff,Roland Flurschütz,Fabian Trillsch,Sven Mahner,Fritz Jänicke,Karin Milde-Langosch +5 more
TL;DR: The results show that Jun proteins (pc-Jun and JunD) influence carcinogenesis and tumour progression, suggesting a significant role as prognostic predictors in human ovarian carcinoma.